RONA HU: Open Payments
NPI 1508991597 · PALO ALTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$869 in 7 payments from 6 companies in 2025. Trend: 2023 $249 · 2024 $289 · 2025 $869
Food & beverage: $869
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $246 |
| Otsuka America Pharmaceutical, Inc. | 1 | $131 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $129 |
| Vanda Pharmaceuticals Inc. | 1 | $125 |
| Neurocrine BioSciences, Inc. | 1 | $121 |
| Alkermes, Inc. | 1 | $118 |
Products named: COBENFY, ABILIFY MAINTENA, CAPLYTA, FANAPT, INGREZZA, LYBALVI.
Industry payments across CA — which companies pay providers there.
